Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Endoscopic submucosal dissection (ESD) has been developed to overcome the limitations
of endoscopic mucosal resection (EMR). Yet, the potential for EMR should not be ignored …

Background and Aims The outcomes of endoscopic submucosal dissection (ESD) for T1b
esophageal cancer (EC) and its recurrence rates remain unclear in the West. Using a …

Esophageal cancer is the sixth leading cause of cancer related mortality worldwide, with a 5-
year survival rate of approximately 20%. 1, 2 There are 2 main histologic subtypes …

Background & Aims Endoscopic resection is an important component of the endoscopic
treatment of Barrett's esophagus (BE) with dysplasia and intramucosal adenocarcinoma …

Background and Aims Data are limited on the role of endoscopic submucosal dissection
(ESD) as a potential diagnostic and staging tool in Barrett's esophagus (BE) neoplasia. We …

Objectives Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection
(ESD) allow endoscopic resection of early esophageal adenocarcinoma. The choice …

Objective. To analyze the efficacy and safety of submucosal tunnel endoscopic resection
(STER) for the treatment of submucosal masses in esophageal muscularis propria. Method …

Worldwide, GLOBOCAN estimated 572,034 new cases of esophageal cancer in 2018, with
508,585 deaths from esophageal cancer. 1 In the United States, the Surveillance …

Methods: The Grading of Recommendations Assessment, Development and Evaluation
(GRADE) framework was used to assess evidence and make recommendations. The panel …